Nobel Laureate Dr. Jennifer Doudna spoke at Fred Hutch Cancer Center in Seattle about strategies to improve CRISPR gene editing and delivery to help make CRISPR-based gene therapies cheaper and easier to access.
Dr. Doudna spoke about her contributions to the development of CRISPR-Cas9, a revolutionary DNA-editing technology, and her lab’s ongoing efforts to improve the efficiency, affordability, and delivery of CRISPR-based gene therapies. In her lecture, Dr.